Efficacy of a Novel Zigzag Application Pattern for Micropulse Transscleral Cyclophotocoagulation for the Management of Glaucoma

被引:0
|
作者
Sami, Ahmed [1 ,3 ]
Aboulnasr, Tarek T. [2 ]
El-Shahed, Ahmed F. [1 ]
机构
[1] Helwan Univ, Fac Med, Cairo, Egypt
[2] Benha Univ, Fac Med, Cairo, Egypt
[3] Helwan Univ, Fac Med, Mokattam City Sq, Cairo 11571, Egypt
关键词
cyclophotocoagulation; laser treatment; refractory glaucoma; micropulse; zigzag; OUTCOMES;
D O I
10.1097/IJG.0000000000002095
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Precis:A zigzag mode of application effectively lowered IOP in glaucoma patients at 6 months with a low incidence of complications despite the longer application time. Comparative studies to assess the potential advantages of treating a larger area of ciliary body with this approach are needed. Purpose:The purpose of this study is to evaluate the clinical outcome of micropulse transscleral laser cyclophotocoagulation with zigzag mode of application in adult glaucomatous patients. Subjects and Methods:A prospective single-arm clinical trial included a series of 34 eyes of 30 consecutive patients who underwent micropulse transscleral cyclophotocoagulation (MP-TSCPC) with zigzag technique at a private ophthalmology center. The trial was conducted from March 16, 2021 to April 12, 2021. Patients who had at least 6 months of follow-up were included. MP-TSCPC probe was moved for 2 mm perpendicular to a line 3 mm parallel to the cornea. This aims to cover the largest circumference of the area supposed to hinder the cilliary body. The probe is moved over 3 quadrants for 90 seconds for each quadrant (total 270 s). Defined as an intraocular pressure (IOP) of 6 to 21 mm Hg or a reduction of IOP by 30%. Failure was defined as an inability to meet the criteria for success or need for retreatment. Results:The mean age of involved patients was 52.9 (& PLUSMN;SD: 3.9) years old. The mean IOP before MP-TSCPC was 37.47 (& PLUSMN;SD: 11.08) mm Hg, which was significantly reduced to 17.7 (& PLUSMN;SD: 7.4) mm Hg in the last follow-up visit at 6 months. Number of medications showed significant reduction from mean 3.44 (& PLUSMN;SD: 0.99) to 1.91 (& PLUSMN;SD: 1.26) in the last follow-up. Success rate was found to be 88% (30 out of 34 eyes) at the final follow-up, where 9 cases showed complete success (26.5%), whereas 21 (61.8%) cases showed qualified success. Despite the relatively higher parameters used in our study, no cases reported postoperative complications apart from only 1 case of reduced visual acuity by 1 line. Conclusions:A zigzag mode of application effectively lowered IOP in glaucoma patients at 6 months with a low incidence of complications despite the longer application time. Comparative studies to assess the potential advantages of treating a larger area of ciliary body with this approach are needed.
引用
收藏
页码:382 / 388
页数:7
相关论文
共 50 条
  • [21] The effects of micropulse transscleral cyclophotocoagulation versus traditional transscleral cyclophotocoagulation diode on intraocular pressure in primary open angle glaucoma
    Patel, Krishna
    Gelinas, Nathaniel
    Rafay, Hammad
    Patrianakos, Thomas
    Giovingo, Michael
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [22] Slow coagulation versus micropulse transscleral cyclophotocoagulation for refractory childhood glaucoma
    Seixas, Regina Cele Silveira
    Russ, Heloisa Helena Abil
    Maestrini, Heloisa Andrade
    Balbino, Marcos
    Fernandes, Thatiana Almeida Pereira
    Lima, Nubia Vanessa dos Anjos
    Lopes, Nara Lidia Vieira
    Neto, Taurino dos Santos Rodrigues
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2024, 34 (06) : 1932 - 1940
  • [23] Micropulse Transscleral Cyclophotocoagulation as Primary Treatment in Pediatric Eyes with Uncontrolled Glaucoma
    Cote, Stephanie Lynne
    Johnston, Julia Victoria
    Reiser, Bibiana
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [24] A retrospective chart review of the efficacy and safety of micropulse transscleral cyclophotocoagulation to treat refractory pediatric glaucoma patients
    Johnston, Julia Victoria
    Cote, Stephanie Lynne
    Reiser, Bibiana
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [25] EFFICACY OF CYCLOCRYOTHERAPY AND TRANSSCLERAL DIODE LASER CYCLOPHOTOCOAGULATION IN THE MANAGEMENT OF REFRACTORY GLAUCOMA
    Miljkovic, Aleksandar
    Babic, Nikola
    Canadanovic, Vladimir A.
    Davidovic, Sofija
    Ljikar, Jelena
    Vasin, Marija
    ACTA CLINICA CROATICA, 2021, 60 (02) : 171 - 177
  • [26] Micropulse transscleral cyclophotocoagulation in canine glaucoma: A retrospective study evaluating sweep velocity
    Benitez-Vera, Valeria
    Bras, Dineli
    Montiani Ferreira, Fabiano
    VETERINARY OPHTHALMOLOGY, 2025, 28 (02) : 293 - 305
  • [27] Glaucoma treatment by transscleral cyclophotocoagulation in micropulse technology in a low-income setting
    Kotula M.A.
    Paust K.
    Wirdemann A.
    Msigomba E.
    Burusu L.
    Die Ophthalmologie, 2022, 119 (12) : 1275 - 1279
  • [28] Outcomes of micropulse transscleral cyclophotocoagulation in primary open-angle glaucoma, pseudoexfoliation glaucoma, and secondary glaucoma
    Tekeli, Oya
    Kose, Helin Ceren
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2021, 31 (03) : 1113 - 1121
  • [29] Preliminary findings in 30 dogs treated with micropulse transscleral cyclophotocoagulation for refractory glaucoma
    Sapienza, John S.
    Kim, Kay
    Rodriguez, Elena
    DiGirolamo, Nicola
    VETERINARY OPHTHALMOLOGY, 2019, 22 (04) : 520 - 528
  • [30] Outcome of Micropulse Laser Transscleral Cyclophotocoagulation on Pediatric Versus Adult Glaucoma Patients
    Lee, Jun Hui
    Shi, Yuhua
    Amoozgar, Behzad
    Aderman, Christopher
    Campomanes, Alejandra De Alba
    Lin, Shan
    Han, Ying
    JOURNAL OF GLAUCOMA, 2017, 26 (10) : 936 - 939